Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.

Shou-Chien HsuShy-Shin ChangMeng-Tse Gabriel LeeSi-Huei LeeYi-Wen TsaiShen-Che LinSzu-Ta ChenYi-Chieh WengLorenzo PortaJiunn-Yih WuChien-Chang Lee

Published in: PloS one (2017)

We found that use of fluoroquinolones was associated with a non-negligible increased risk of gastrointestinal perforation, and physicians should be aware of this possible association.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
primary care
chronic kidney disease
prognostic factors
stem cells
cell therapy
bone marrow
replacement therapy